Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Karyopharm Therapeutics Inc note 3.000%10/1
Tip: Access up to 7 years of quarterly data
All positions including Karyopharm Therapeutics Inc note 3.000%10/1 held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Karyopharm Therapeutics Inc note 3.000%10/1 by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $25k | 38k | 0.65 |
2024-06-30 | $25k | 38k | 0.65 |
2024-03-31 | $20k | 38k | 0.53 |
2023-12-31 | $19k | 38k | 0.51 |
2023-09-30 | $26k | 38k | 0.68 |
2023-06-30 | $26k | 38k | 0.68 |
2023-03-31 | $29k | 38k | 0.76 |
2022-06-30 | $655k | 900k | 0.73 |
2022-03-31 | $2.9M | 3.5M | 0.82 |
2021-12-31 | $4.3M | 5.3M | 0.81 |
2021-03-31 | $3.3M | 3.0M | 1.11 |
2020-12-31 | $3.9M | 3.0M | 1.30 |
2020-09-30 | $6.9M | 5.5M | 1.27 |
2019-12-31 | $2.7M | 1.8M | 1.46 |
Top funds holding Karyopharm Therapeutics Inc note 3.000%10/1
View all funds holding Karyopharm Therapeutics Inc note 3.000%10/1